Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Depression: HELP
Yena L. Lee
Based on 33 articles published since 2008
||||
Expertise Level
The expertise of Yena L. Lee ranks in the
  • Top 0.079%
  • ... of 222,592 published authors worldwide on Depression
  • ... from 2008 through 2019
  • ... based on contributions to 33 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Lee, Yena   ·   Lee, Yena L
Work Locations
Details
Most likely:    University Health Network of Toronto      
2019
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Institute of Medical Science, University of Toronto, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, Brazil. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Institute of Medical Science, University of Toronto, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Department of Pharmacology, University of Toronto, Toronto, Canada. Electronic address: · Pubmed 30795495
2018
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. Electronic address: · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, Federal University of São Paulo, São Paulo, SP, Brazil. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Brain and Cognition Discovery Foundation, Toronto, ON, Canada. · Pubmed 30031025
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Department of Psychiatry, Federal University of São Paulo, São Paulo 05403-903, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada. · Department of Pharmacology, University of Toronto, 399 Bathurst Street, Toronto, ON M5T 2S8, Canada. · Pubmed 29673146
  • Institute of Medical Science, University of Toronto, Toronto, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada. · Paik Institute for Clinical Research, Inje University, Busan, Republic of Korea; Department of Health Science and Technology, Graduate School, Inje University, Busan, Republic of Korea; Department of Psychiatry, School of Medicine, Haeundae Paik Hospital, Busan, Republic of Korea. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, Universidade Federal de Sao Paulo, Sao Paulo, Brazil. · Department of Psychiatry, Ansan Hospital, College of Medicine, Korea University, Ansan, Republic of Korea. · Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. · Institute of Medical Science, University of Toronto, Toronto, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Department of Pharmacology, University of Toronto, Toronto, Canada. Electronic address: · Pubmed 29154157
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada; Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Faculty of Medicine, Queensland University, Brisbane, Queensland, Australia. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada. Electronic address: · Pubmed 28992527
  • Institute of Medical Science, University of Toronto, Toronto, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada. · Department of Mechanical and Industrial Engineering, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, Brazil. · Laboratory of Emotion and Cognition, Department of Affective Disorders, Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China; Department of Neuropsychology, University of Hong Kong, Hong Kong, China. · School of Medicine, Chang Gung University, Taoyuan, Taiwan; Department of Psychiatry, Chang Gung Memorial Hospital, Chiayi, Taiwan. · Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. · Institute of Medical Science, University of Toronto, Toronto, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Department of Pharmacology, University of Toronto, Toronto, Canada. Electronic address: · Pubmed 30153635
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, Samsung Seoul Hospital, Sungkyunkwan University, School of Medicine, Seoul, Republic of Korea. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Paik Institute for Clinical Research, Inje University, Busan, Republic of Korea. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, College of Medicine, Imam University, Riyadh, Saudi Arabia. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; American University of Integrative Sciences School of Medicine, Sint Maarten, The Netherlands. · Alzheimer Center, VU Medical Center, Amsterdam, The Netherlands; Metis Cognition Ltd., Warminster, UK. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 29886204
  • Dent Neurologic Institute, Amherst, NY, USA. · University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, USA. · Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada. · Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada. · Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada. · Pubmed 29427512
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada. · Smofsky Strategic Planning, Oakville, Ontario, Canada. · AstraZeneca Canada, Mississauga, Ontario, Canada. · Lewis-Daly & Associates, Toronto, Ontario, Canada. · The Health Team, Toronto, Ontario, Canada. · Department of Health Research Methods, Evidence, and Impact; Center for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, Ontario, Canada; Research Institute at St Joes, St Joseph Healthcare Hamilton, Hamilton, Ontario, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada. Electronic address: · Pubmed 28958785
2017
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · The Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada. · Department of Pharmacology, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Brain and Cognition Discovery Foundation, Toronto, ON, Canada. · Pubmed 28933261
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON, Canada; American University of Integrative Sciences School of Medicine, Sint Maarten, The Netherlands. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON, Canada. · Department of Psychological Medicine, National University of Singapore, Singapore. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 28501518
  • a Department of Psychiatry , University of Toronto , Toronto , Canada. · b Mood Disorders Psychopharmacology Unit , University Health Network , Toronto , Canada. · c Brain and Cognition Discovery Foundation , Toronto , Canada. · d Neuralstem , 20271 Goldenrod Lane, Germantown , MD 20876 , USA. · Pubmed 28460574
  • 1Department of Psychiatry,University of California,San Diego,California,USA. · 3Neuroscience Education Institute,Carlsbad,California,USA. · 4Lucio Bini Mood Disorders Center,New York,New York,USA. · 5Department of Psychiatry,Massachusetts General Hospital,Boston,Massachusetts,USA. · 6Department of Psychiatry,Icahn School of Medicine at Mount Sinai,New York,New York,USA. · 7Research Institute at the Lindner Center of HOPE,Mason,Ohio,USA. · 8Mood Disorders Psychopharmacology Unit,University Health Network,Toronto,Ontario,Canada. · 10Department of Psychiatry,University of Sydney,Sydney,Australia. · 11Centro Lucio Bini,Rome,Italy. · 12VA Palo Alto Health Care System,Palo Alto,California,USA. · 14Hospital Clinic,Institute of Neuroscience,University of Barcelona,IDIBAPS,CIBERSAM,Barcelona,Catalonia,Spain. · 15Psychiatry Clinic,Sainen,Kanazawa City,Ishikawa Prefecture,Japan. · 16Department of Psychiatry,Perelman School of Medicine,University of Pennsylvania, and the Corporal Michael J. Crescenz Veterans Affairs Medical Center,Philadelphia,Pennsylvania,USA. · 17Department of Psychological Medicine,Kings College,London,United Kingdom. · 18Department of Psychiatry,Rhode Island Hospital,Providence,Rhode Island,USA. · Pubmed 28421980
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Janssen Research & Development, LLC, Raritan, USA. · Department of Psychiatry, St. Michael's Hospital, Toronto, ON, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Department of Pharmacology, University of Toronto, Toronto, ON, Canada. · Pubmed 27913990
  • Department of Psychiatry, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; Department of Pharmacology, Faculty of Science, Mahidol University, Bangkok, Thailand. Electronic address: · Department of Psychiatry, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Pubmed 27498907
  • a Medical Sciences, Dalhousie University , Halifax , NS , Canada. · b Mood Disorders Psychopharmacology Unit, University Health Network , Toronto , ON , Canada. · c Department of Psychiatry , University of Toronto , Toronto , ON , Canada. · d Institute of Medical Science, University of Toronto , Toronto , ON , Canada. · e Department of Psychiatry , Western University , London and Windsor , ON , Canada. · f Department of Pharmacology , University of Toronto , Toronto , ON , Canada. · Pubmed 26752601
  • Department of Psychiatry and Pharmacology, University of Toronto, Mood Disorders Psychopharmacology Unit, University Health Network, Brain and Cognition Discovery Foundation, 399 Bathurst St, Toronto, ON, Canada M5T 2S8. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Brain and Cognition Discovery Foundation (BCDF), Toronto, Canada. · Department of Psychiatry, University of Toronto, Toronto, Canada. · Department of Pharmacology, University of Toronto, Toronto, Canada. · Institute of Medical Science, University of Toronto, Toronto, Canada. · Department of Psychology, Queen's University, Kingston, Canada. · Centre for Addiction and Mental Health, Toronto, Canada. · Faculty of Medicine, University of Queensland, Brisbane, Australia. · Stoneylane Clinic Drogheda, Co Louth, Ireland. · Department of Psychiatry, University of Adelaide, Adelaide, Australia. · Department of Family Medicine, Boston University, Boston, Massachusetts, USA. · Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, Institut du Cerveau et de la Moelle, ICM, Social and Affective Neuroscience (SAN) Team, Paris, France. · Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas, USA. · University Department of Psychiatry, Warneford Hospital, Oxford, United Kingdom. · Private practice, London, United Kingdom. · Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada. · Institute of Clinical Psychology and Psychotherapy and Centre of Clinical Epidemiology and Longitudinal Studies (CELOS), Technische Universität Dresden, Dresden, Germany. · Alzheimer Center, VU Medical Center, Amsterdam, the Netherlands. · Metis Cognition Ltd, Warminster, United Kingdom. · IoPPN, King's College, London, United Kingdom. · Pubmed 28858441
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, Samsung Seoul Hospital, Sungkyunkwan University, School of Medicine, Seoul, Republic of Korea. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Paik Institute for Clinical Research, Inje University, Busan, Republic of Korea. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, College of Medicine, Imam University, Riyadh, Saudi Arabia. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; American University of Integrative Sciences School of Medicine, Sint Maarten, The Netherlands. · Alzheimer Center, VU Medical Center, Amsterdam, The Netherlands; Metis Cognition Ltd., Warminster, UK. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 28850348
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, Samsung Seoul Hospital, Sungkyunkwan University, School of medicine, Seoul, Republic of Korea. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Paik Institute for Clinical Research, Inje University, Busan, Republic of Korea. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; American University of Integrative Sciences, School of Medicine, Sint Maarten. · Associate Professor, Center for Depression Research and Clinical Care, Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA. · Associate Head for Research, Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada; Director, Mood Disorders Centre, Djavad Mowafaghian Centre for Brain Health, Vancouver, BC, Canada; Executive Chair, Canadian Network for Mood and Anxiety Treatments (CANMAT), Vancouver, BC, Canada. · Professor and Chair, Head of Discipline of Psychiatry, University of Adelaide, Adelaide, Australia. · Associate Professor, Alzheimer Center, VU Medical Center, Amsterdam, The Netherlands; Principal Consultant, Metis Cognition Ltd., Warminster, UK. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada; Professor, Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Professor, Department of Pharmacology, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 28667888
  • Department of Psychiatry, Chang Gung Medical Foundation, Chiayi Chang Gung Memorial Hospital, Chiayi, Taiwan. · Department of Psychiatry, School of Medicine, Chang Gung University, Taoyuan, Taiwan. · Tsaotun Psychiatric Center, Ministry of Health and Welfare, Nan-Tou County, Taiwan. · PhD Student of Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan. · Department of Psychiatry, Cathay General Hospital, Taipei, Taiwan. · College of Medicine, Fu Jen Catholic University, Taipei, Taiwan. · Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Toronto, Canada. · Departments of Psychiatry and Pharmacology, University of Toronto, Toronto, Canada. · Department of Medical Imaging and Radiological Sciences, Chung Shan Medical University, Taichung, Taiwan. · Institute of Occupational Medicine and Industrial Hygiene, National Taiwan University College of Public Health, Taipei, Taiwan. · Department of Neurology, Kaoshiung Medical University Hospital, Kaoshiung, Taiwan. · Department of Environmental and Occupational Medicine, National Taiwan University Hospital, Taipei, Taiwan. · Pubmed 28257449
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Ontario, Canada; Department of Psychiatry, Samsung Seoul Hospital, Sungkyunkwan University, School of Medicine, Seoul, South Korea. · Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University, School of Medicine, Seoul, South Korea. · Departments of Preventive Medicine, School of Medicine, Kyung Hee University, Seoul, South Korea. · Cancer Registration and Statistic Branch, National Cancer Control Institute, National Cancer Center, Goyang, South Korea. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Ontario, Canada; Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), Brazil. · Department of Medicine, Schulich School of Medicine and Dentistry, University of Western London, Ontario, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Institute of Medical Science, University of Tornoto, Toronto, Ontario, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Ontario, Canada; Institute of Medical Science, University of Tornoto, Toronto, Ontario, Canada; Department of Pharmacology, University of Toronto, Ontario, Canada. Electronic address: · Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University, School of Medicine, Seoul, South Korea; Departments of Preventive Medicine, School of Medicine, Kyung Hee University, Seoul, South Korea. Electronic address: · Pubmed 27810270
2016
  • 1Mood Disorders Psychopharmacology Unit,University Health Network,Toronto,Ontario,Canada. · Pubmed 28044944
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada. · Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada. · Pubmed 27935809
  • From the *Mood Disorders Psychopharmacology Unit, University Health Network; †Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada; ‡Psychiatric Center Copenhagen, Department O, Copenhagen, Denmark; and Departments of §Psychiatry and ∥Pharmacology, University of Toronto, Toronto, Ontario, Canada. · Pubmed 26658082
  • School of Medicine, Chang Gung University, Taoyuan, Taiwan; Department of Psychiatry, Chang Gung Memorial Hospital, Chiayi, Taiwan. · Department of Medical Imaging and Radiological Sciences, Chung Shan Medical University, Taichung, Taiwan; Department of Medical Imaging, Chung Shan Medical University Hospital, Taichung, Taiwan. · School of Medicine, Chang Gung University, Taoyuan, Taiwan; Department of Psychiatry, Chang Gung Memorial Hospital, Taoyuan, Taiwan. · Department of Medical Imaging and Radiological Sciences, Chung Shan Medical University, Taichung, Taiwan. · Department of Psychiatry, Chung Shan Medical University, Taichung, Taiwan. · Department of Neurosurgery, Chang Gung Memorial Hospital, Taoyuan, Taiwan. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada. · Department of Medical Imaging and Radiological Sciences, Chung Shan Medical University, Taichung, Taiwan; Department of Medical Imaging, Chung Shan Medical University Hospital, Taichung, Taiwan. Electronic address: · Pubmed 27423425
  • 1Department of Psychiatry,University of Toronto,Toronto,Ontario,Canada. · 3Mood Disorders Psychopharmacology Unit,University Health Network,Toronto,Ontario,Canada. · 5Department of Psychiatry,Psychiatric Center,Copenhagen,Denmark. · 6Cleveland Clinic,Cleveland,Ohio,USA. · 7Turn2Health Solutions,Willoughby,Ohio,USA. · 8Translational Psychiatry Research Group and Department of Clinical Medicine, Faculty of Medicine,Federal University of Ceara,Fortaleza,Brazil. · 9Department of Neuropsychiatry,University of South Carolina School of Medicine,Columbia,South Carolina,USA. · Pubmed 26714651
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Cleveland Clinic, Cleveland, OH, USA. · Turn2Health Solutions, Willoughby, OH, USA. · Translational Psychiatry Research Group and Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceara, Fortaleza, Brazil. · Department of Neuropsychiatry, University of South Carolina School of Medicine, USA. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 26508286
2015
  • 1Department of Psychiatry,University of Toronto,Toronto,Ontario,Canada. · 3Mood Disorders Psychopharmacology Unit,University Health Network,Toronto,Ontario,Canada. · Pubmed 26683526
2017
  • From the *Mood Disorder Psychopharmacology Unit, University Health Network; †Brain and Cognition Discovery Foundation, ‡Department of Psychiatry, §Department of Pharmacology, and ∥Institute of Medical Science, University of Toronto, Toronto, ON, Canada; ¶Department of Psychiatry, University of Saskatchewan, Saskatoon, SK, Canada; #Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada; and **Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, SC. · Pubmed 28590365
2016
  • aDepartment of PsychiatrybDepartment of Pharmacology, University of TorontocMood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Pubmed 26575300
Probable:    University of Toronto   Contact    
2019
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Institute of Medical Science, University of Toronto, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, Brazil. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Institute of Medical Science, University of Toronto, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Department of Pharmacology, University of Toronto, Toronto, Canada. Electronic address: · Pubmed 30795495
2018
  • From the Mood Disorders Psychopharmacology Unit, University Health Network, Canada · Institute of Medical Science (Drs. McIntyre and Rosenblat, Ms. Lee, and Mr. Pan), Department of Psychiatry (Drs. McIntyre, Rosenblat, and Mansur), and Department of Pharmacology (Dr. McIntyre), University of Toronto · Paik Institute for Clinical Research, Inje University (Republic of Korea) (Dr. J Lee) · Department of Psychiatry, Samsung Seoul Hospital, Sungkyunkwan University, School of Medicine (Republic of Korea) (Dr. J-G Lee) · Department of Psychiatry, College of Medicine, Imam University (Saudi Arabia) (Dr. Alageel). · Pubmed 30188336
  • Resident of Psychiatry, Clinician Scientist Stream, University of Toronto, Toronto, Ontario, Canada,. Electronic address: · Graduate Student, University of Toronto, Toronto, Ontario, Canada,. Electronic address: · Head, Mood Disorder Psychopharmacology Unit, University Health Network, Professor of Psychiatry and Pharmacology, University of Toronto, 399 Bathurst Street, MP 9-325, Toronto, Ontario M5T 2S8, Canada,. Electronic address: · Pubmed 30149336
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. Electronic address: · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, Federal University of São Paulo, São Paulo, SP, Brazil. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Brain and Cognition Discovery Foundation, Toronto, ON, Canada. · Pubmed 30031025
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Department of Psychiatry, Federal University of São Paulo, São Paulo 05403-903, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada. · Department of Pharmacology, University of Toronto, 399 Bathurst Street, Toronto, ON M5T 2S8, Canada. · Pubmed 29673146
  • Institute of Medical Science, University of Toronto, Toronto, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada. · Paik Institute for Clinical Research, Inje University, Busan, Republic of Korea; Department of Health Science and Technology, Graduate School, Inje University, Busan, Republic of Korea; Department of Psychiatry, School of Medicine, Haeundae Paik Hospital, Busan, Republic of Korea. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, Universidade Federal de Sao Paulo, Sao Paulo, Brazil. · Department of Psychiatry, Ansan Hospital, College of Medicine, Korea University, Ansan, Republic of Korea. · Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. · Institute of Medical Science, University of Toronto, Toronto, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Department of Pharmacology, University of Toronto, Toronto, Canada. Electronic address: · Pubmed 29154157
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada; Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Faculty of Medicine, Queensland University, Brisbane, Queensland, Australia. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada. Electronic address: · Pubmed 28992527
  • Institute of Medical Science, University of Toronto, Toronto, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada. · Department of Mechanical and Industrial Engineering, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, Brazil. · Laboratory of Emotion and Cognition, Department of Affective Disorders, Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China; Department of Neuropsychology, University of Hong Kong, Hong Kong, China. · School of Medicine, Chang Gung University, Taoyuan, Taiwan; Department of Psychiatry, Chang Gung Memorial Hospital, Chiayi, Taiwan. · Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. · Institute of Medical Science, University of Toronto, Toronto, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Department of Pharmacology, University of Toronto, Toronto, Canada. Electronic address: · Pubmed 30153635
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, Samsung Seoul Hospital, Sungkyunkwan University, School of Medicine, Seoul, Republic of Korea. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Paik Institute for Clinical Research, Inje University, Busan, Republic of Korea. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, College of Medicine, Imam University, Riyadh, Saudi Arabia. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; American University of Integrative Sciences School of Medicine, Sint Maarten, The Netherlands. · Alzheimer Center, VU Medical Center, Amsterdam, The Netherlands; Metis Cognition Ltd., Warminster, UK. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 29886204
  • Dent Neurologic Institute, Amherst, NY, USA. · University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, USA. · Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada. · Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada. · Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada. · Pubmed 29427512
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada. · Smofsky Strategic Planning, Oakville, Ontario, Canada. · AstraZeneca Canada, Mississauga, Ontario, Canada. · Lewis-Daly & Associates, Toronto, Ontario, Canada. · The Health Team, Toronto, Ontario, Canada. · Department of Health Research Methods, Evidence, and Impact; Center for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, Ontario, Canada; Research Institute at St Joes, St Joseph Healthcare Hamilton, Hamilton, Ontario, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada. Electronic address: · Pubmed 28958785
2017
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · The Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada. · Department of Pharmacology, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Brain and Cognition Discovery Foundation, Toronto, ON, Canada. · Pubmed 28933261
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON, Canada; American University of Integrative Sciences School of Medicine, Sint Maarten, The Netherlands. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON, Canada. · Department of Psychological Medicine, National University of Singapore, Singapore. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 28501518
  • Resident of Psychiatry, Clinician Scientist Stream, University of Toronto, Ontario, Canada. · Undergraduate Research Student, University of Toronto, Ontario, Canada. · 399 Bathurst St, MP 9-325, Toronto, Ontario M5T 2S8, Canada. · Department of Psychiatry and Pharmacology, Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Ontario, Canada. · Pubmed 28068459
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Janssen Research & Development, LLC, Raritan, USA. · Department of Psychiatry, St. Michael's Hospital, Toronto, ON, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Department of Pharmacology, University of Toronto, Toronto, ON, Canada. · Pubmed 27913990
  • Department of Psychiatry and Pharmacology, University of Toronto, Mood Disorders Psychopharmacology Unit, University Health Network, Brain and Cognition Discovery Foundation, 399 Bathurst St, Toronto, ON, Canada M5T 2S8. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Brain and Cognition Discovery Foundation (BCDF), Toronto, Canada. · Department of Psychiatry, University of Toronto, Toronto, Canada. · Department of Pharmacology, University of Toronto, Toronto, Canada. · Institute of Medical Science, University of Toronto, Toronto, Canada. · Department of Psychology, Queen's University, Kingston, Canada. · Centre for Addiction and Mental Health, Toronto, Canada. · Faculty of Medicine, University of Queensland, Brisbane, Australia. · Stoneylane Clinic Drogheda, Co Louth, Ireland. · Department of Psychiatry, University of Adelaide, Adelaide, Australia. · Department of Family Medicine, Boston University, Boston, Massachusetts, USA. · Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, Institut du Cerveau et de la Moelle, ICM, Social and Affective Neuroscience (SAN) Team, Paris, France. · Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas, USA. · University Department of Psychiatry, Warneford Hospital, Oxford, United Kingdom. · Private practice, London, United Kingdom. · Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada. · Institute of Clinical Psychology and Psychotherapy and Centre of Clinical Epidemiology and Longitudinal Studies (CELOS), Technische Universität Dresden, Dresden, Germany. · Alzheimer Center, VU Medical Center, Amsterdam, the Netherlands. · Metis Cognition Ltd, Warminster, United Kingdom. · IoPPN, King's College, London, United Kingdom. · Pubmed 28858441
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, Samsung Seoul Hospital, Sungkyunkwan University, School of Medicine, Seoul, Republic of Korea. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Paik Institute for Clinical Research, Inje University, Busan, Republic of Korea. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, College of Medicine, Imam University, Riyadh, Saudi Arabia. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; American University of Integrative Sciences School of Medicine, Sint Maarten, The Netherlands. · Alzheimer Center, VU Medical Center, Amsterdam, The Netherlands; Metis Cognition Ltd., Warminster, UK. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 28850348
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, Samsung Seoul Hospital, Sungkyunkwan University, School of medicine, Seoul, Republic of Korea. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Paik Institute for Clinical Research, Inje University, Busan, Republic of Korea. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; American University of Integrative Sciences, School of Medicine, Sint Maarten. · Associate Professor, Center for Depression Research and Clinical Care, Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA. · Associate Head for Research, Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada; Director, Mood Disorders Centre, Djavad Mowafaghian Centre for Brain Health, Vancouver, BC, Canada; Executive Chair, Canadian Network for Mood and Anxiety Treatments (CANMAT), Vancouver, BC, Canada. · Professor and Chair, Head of Discipline of Psychiatry, University of Adelaide, Adelaide, Australia. · Associate Professor, Alzheimer Center, VU Medical Center, Amsterdam, The Netherlands; Principal Consultant, Metis Cognition Ltd., Warminster, UK. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada; Professor, Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Professor, Department of Pharmacology, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 28667888
  • Department of Psychiatry, Chang Gung Medical Foundation, Chiayi Chang Gung Memorial Hospital, Chiayi, Taiwan. · Department of Psychiatry, School of Medicine, Chang Gung University, Taoyuan, Taiwan. · Tsaotun Psychiatric Center, Ministry of Health and Welfare, Nan-Tou County, Taiwan. · PhD Student of Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan. · Department of Psychiatry, Cathay General Hospital, Taipei, Taiwan. · College of Medicine, Fu Jen Catholic University, Taipei, Taiwan. · Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Toronto, Canada. · Departments of Psychiatry and Pharmacology, University of Toronto, Toronto, Canada. · Department of Medical Imaging and Radiological Sciences, Chung Shan Medical University, Taichung, Taiwan. · Institute of Occupational Medicine and Industrial Hygiene, National Taiwan University College of Public Health, Taipei, Taiwan. · Department of Neurology, Kaoshiung Medical University Hospital, Kaoshiung, Taiwan. · Department of Environmental and Occupational Medicine, National Taiwan University Hospital, Taipei, Taiwan. · Pubmed 28257449
2016
  • From the *Mood Disorders Psychopharmacology Unit, University Health Network; †Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada; ‡Psychiatric Center Copenhagen, Department O, Copenhagen, Denmark; and Departments of §Psychiatry and ∥Pharmacology, University of Toronto, Toronto, Ontario, Canada. · Pubmed 26658082
2017
  • From the *Mood Disorder Psychopharmacology Unit, University Health Network; †Brain and Cognition Discovery Foundation, ‡Department of Psychiatry, §Department of Pharmacology, and ∥Institute of Medical Science, University of Toronto, Toronto, ON, Canada; ¶Department of Psychiatry, University of Saskatchewan, Saskatoon, SK, Canada; #Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada; and **Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, SC. · Pubmed 28590365
Probable:    Sungkyunkwan University      
2018
  • From the Mood Disorders Psychopharmacology Unit, University Health Network, Canada · Institute of Medical Science (Drs. McIntyre and Rosenblat, Ms. Lee, and Mr. Pan), Department of Psychiatry (Drs. McIntyre, Rosenblat, and Mansur), and Department of Pharmacology (Dr. McIntyre), University of Toronto · Paik Institute for Clinical Research, Inje University (Republic of Korea) (Dr. J Lee) · Department of Psychiatry, Samsung Seoul Hospital, Sungkyunkwan University, School of Medicine (Republic of Korea) (Dr. J-G Lee) · Department of Psychiatry, College of Medicine, Imam University (Saudi Arabia) (Dr. Alageel). · Pubmed 30188336
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 33 total) written by Yena L. Lee about Depression:

  • The long-term effect of bariatric surgery on depression and anxiety. 2019
  • Characterizing, Assessing, and Treating Cognitive Dysfunction in Major Depressive Disorder. 2018
  • The effect of pharmacogenomic testing on response and remission rates in the acute treatment of major depressive disorder: A meta-analysis. 2018
  • Predicting antidepressant response using early changes in cognition: A systematic review. 2018
  • Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder. 2018
  • Efficacy of antidepressants on measures of workplace functioning in major depressive disorder: A systematic review. 2018
  • Sex differences in the mediators of functional disability in Major Depressive Disorder. 2018
  • Applications of machine learning algorithms to predict therapeutic outcomes in depression: A meta-analysis and systematic review. 2018
  • Cognitive impairment as measured by the THINC-integrated tool (THINC-it): The association with self-reported anxiety in Major Depressive Disorder. 2018
  • The use of brexpiprazole amongst individuals with insufficient outcomes with aripiprazole or bupropion: A case series. 2018
Show List of Full Article Records
Google Searches

Learn more about Yena L. Lee using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University Health Network of Toronto
University of Toronto
Sungkyunkwan University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University Health Network of Toronto
2019
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Institute of Medical Science, University of Toronto, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, Brazil. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Institute of Medical Science, University of Toronto, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Department of Pharmacology, University of Toronto, Toronto, Canada. Electronic address: · Pubmed 30795495
2018
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. Electronic address: · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, Federal University of São Paulo, São Paulo, SP, Brazil. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Brain and Cognition Discovery Foundation, Toronto, ON, Canada. · Pubmed 30031025
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Department of Psychiatry, Federal University of São Paulo, São Paulo 05403-903, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada. · Department of Pharmacology, University of Toronto, 399 Bathurst Street, Toronto, ON M5T 2S8, Canada. · Pubmed 29673146
  • Institute of Medical Science, University of Toronto, Toronto, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada. · Paik Institute for Clinical Research, Inje University, Busan, Republic of Korea; Department of Health Science and Technology, Graduate School, Inje University, Busan, Republic of Korea; Department of Psychiatry, School of Medicine, Haeundae Paik Hospital, Busan, Republic of Korea. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, Universidade Federal de Sao Paulo, Sao Paulo, Brazil. · Department of Psychiatry, Ansan Hospital, College of Medicine, Korea University, Ansan, Republic of Korea. · Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. · Institute of Medical Science, University of Toronto, Toronto, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Department of Pharmacology, University of Toronto, Toronto, Canada. Electronic address: · Pubmed 29154157
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada; Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Faculty of Medicine, Queensland University, Brisbane, Queensland, Australia. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada. Electronic address: · Pubmed 28992527
  • Institute of Medical Science, University of Toronto, Toronto, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada. · Department of Mechanical and Industrial Engineering, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, Brazil. · Laboratory of Emotion and Cognition, Department of Affective Disorders, Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China; Department of Neuropsychology, University of Hong Kong, Hong Kong, China. · School of Medicine, Chang Gung University, Taoyuan, Taiwan; Department of Psychiatry, Chang Gung Memorial Hospital, Chiayi, Taiwan. · Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. · Institute of Medical Science, University of Toronto, Toronto, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Department of Pharmacology, University of Toronto, Toronto, Canada. Electronic address: · Pubmed 30153635
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, Samsung Seoul Hospital, Sungkyunkwan University, School of Medicine, Seoul, Republic of Korea. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Paik Institute for Clinical Research, Inje University, Busan, Republic of Korea. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, College of Medicine, Imam University, Riyadh, Saudi Arabia. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; American University of Integrative Sciences School of Medicine, Sint Maarten, The Netherlands. · Alzheimer Center, VU Medical Center, Amsterdam, The Netherlands; Metis Cognition Ltd., Warminster, UK. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 29886204
  • Dent Neurologic Institute, Amherst, NY, USA. · University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, USA. · Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada. · Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada. · Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada. · Pubmed 29427512
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada. · Smofsky Strategic Planning, Oakville, Ontario, Canada. · AstraZeneca Canada, Mississauga, Ontario, Canada. · Lewis-Daly & Associates, Toronto, Ontario, Canada. · The Health Team, Toronto, Ontario, Canada. · Department of Health Research Methods, Evidence, and Impact; Center for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, Ontario, Canada; Research Institute at St Joes, St Joseph Healthcare Hamilton, Hamilton, Ontario, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada. Electronic address: · Pubmed 28958785
2017
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · The Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada. · Department of Pharmacology, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Brain and Cognition Discovery Foundation, Toronto, ON, Canada. · Pubmed 28933261
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON, Canada; American University of Integrative Sciences School of Medicine, Sint Maarten, The Netherlands. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON, Canada. · Department of Psychological Medicine, National University of Singapore, Singapore. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 28501518
  • a Department of Psychiatry , University of Toronto , Toronto , Canada. · b Mood Disorders Psychopharmacology Unit , University Health Network , Toronto , Canada. · c Brain and Cognition Discovery Foundation , Toronto , Canada. · d Neuralstem , 20271 Goldenrod Lane, Germantown , MD 20876 , USA. · Pubmed 28460574
  • 1Department of Psychiatry,University of California,San Diego,California,USA. · 3Neuroscience Education Institute,Carlsbad,California,USA. · 4Lucio Bini Mood Disorders Center,New York,New York,USA. · 5Department of Psychiatry,Massachusetts General Hospital,Boston,Massachusetts,USA. · 6Department of Psychiatry,Icahn School of Medicine at Mount Sinai,New York,New York,USA. · 7Research Institute at the Lindner Center of HOPE,Mason,Ohio,USA. · 8Mood Disorders Psychopharmacology Unit,University Health Network,Toronto,Ontario,Canada. · 10Department of Psychiatry,University of Sydney,Sydney,Australia. · 11Centro Lucio Bini,Rome,Italy. · 12VA Palo Alto Health Care System,Palo Alto,California,USA. · 14Hospital Clinic,Institute of Neuroscience,University of Barcelona,IDIBAPS,CIBERSAM,Barcelona,Catalonia,Spain. · 15Psychiatry Clinic,Sainen,Kanazawa City,Ishikawa Prefecture,Japan. · 16Department of Psychiatry,Perelman School of Medicine,University of Pennsylvania, and the Corporal Michael J. Crescenz Veterans Affairs Medical Center,Philadelphia,Pennsylvania,USA. · 17Department of Psychological Medicine,Kings College,London,United Kingdom. · 18Department of Psychiatry,Rhode Island Hospital,Providence,Rhode Island,USA. · Pubmed 28421980
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Janssen Research & Development, LLC, Raritan, USA. · Department of Psychiatry, St. Michael's Hospital, Toronto, ON, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Department of Pharmacology, University of Toronto, Toronto, ON, Canada. · Pubmed 27913990
  • Department of Psychiatry, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand; Department of Pharmacology, Faculty of Science, Mahidol University, Bangkok, Thailand. Electronic address: · Department of Psychiatry, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Pubmed 27498907
  • a Medical Sciences, Dalhousie University , Halifax , NS , Canada. · b Mood Disorders Psychopharmacology Unit, University Health Network , Toronto , ON , Canada. · c Department of Psychiatry , University of Toronto , Toronto , ON , Canada. · d Institute of Medical Science, University of Toronto , Toronto , ON , Canada. · e Department of Psychiatry , Western University , London and Windsor , ON , Canada. · f Department of Pharmacology , University of Toronto , Toronto , ON , Canada. · Pubmed 26752601
  • Department of Psychiatry and Pharmacology, University of Toronto, Mood Disorders Psychopharmacology Unit, University Health Network, Brain and Cognition Discovery Foundation, 399 Bathurst St, Toronto, ON, Canada M5T 2S8. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Brain and Cognition Discovery Foundation (BCDF), Toronto, Canada. · Department of Psychiatry, University of Toronto, Toronto, Canada. · Department of Pharmacology, University of Toronto, Toronto, Canada. · Institute of Medical Science, University of Toronto, Toronto, Canada. · Department of Psychology, Queen's University, Kingston, Canada. · Centre for Addiction and Mental Health, Toronto, Canada. · Faculty of Medicine, University of Queensland, Brisbane, Australia. · Stoneylane Clinic Drogheda, Co Louth, Ireland. · Department of Psychiatry, University of Adelaide, Adelaide, Australia. · Department of Family Medicine, Boston University, Boston, Massachusetts, USA. · Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, Institut du Cerveau et de la Moelle, ICM, Social and Affective Neuroscience (SAN) Team, Paris, France. · Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas, USA. · University Department of Psychiatry, Warneford Hospital, Oxford, United Kingdom. · Private practice, London, United Kingdom. · Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada. · Institute of Clinical Psychology and Psychotherapy and Centre of Clinical Epidemiology and Longitudinal Studies (CELOS), Technische Universität Dresden, Dresden, Germany. · Alzheimer Center, VU Medical Center, Amsterdam, the Netherlands. · Metis Cognition Ltd, Warminster, United Kingdom. · IoPPN, King's College, London, United Kingdom. · Pubmed 28858441
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, Samsung Seoul Hospital, Sungkyunkwan University, School of Medicine, Seoul, Republic of Korea. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Paik Institute for Clinical Research, Inje University, Busan, Republic of Korea. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, College of Medicine, Imam University, Riyadh, Saudi Arabia. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; American University of Integrative Sciences School of Medicine, Sint Maarten, The Netherlands. · Alzheimer Center, VU Medical Center, Amsterdam, The Netherlands; Metis Cognition Ltd., Warminster, UK. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 28850348
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, Samsung Seoul Hospital, Sungkyunkwan University, School of medicine, Seoul, Republic of Korea. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Paik Institute for Clinical Research, Inje University, Busan, Republic of Korea. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; American University of Integrative Sciences, School of Medicine, Sint Maarten. · Associate Professor, Center for Depression Research and Clinical Care, Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA. · Associate Head for Research, Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada; Director, Mood Disorders Centre, Djavad Mowafaghian Centre for Brain Health, Vancouver, BC, Canada; Executive Chair, Canadian Network for Mood and Anxiety Treatments (CANMAT), Vancouver, BC, Canada. · Professor and Chair, Head of Discipline of Psychiatry, University of Adelaide, Adelaide, Australia. · Associate Professor, Alzheimer Center, VU Medical Center, Amsterdam, The Netherlands; Principal Consultant, Metis Cognition Ltd., Warminster, UK. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada; Professor, Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Professor, Department of Pharmacology, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 28667888
  • Department of Psychiatry, Chang Gung Medical Foundation, Chiayi Chang Gung Memorial Hospital, Chiayi, Taiwan. · Department of Psychiatry, School of Medicine, Chang Gung University, Taoyuan, Taiwan. · Tsaotun Psychiatric Center, Ministry of Health and Welfare, Nan-Tou County, Taiwan. · PhD Student of Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan. · Department of Psychiatry, Cathay General Hospital, Taipei, Taiwan. · College of Medicine, Fu Jen Catholic University, Taipei, Taiwan. · Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Toronto, Canada. · Departments of Psychiatry and Pharmacology, University of Toronto, Toronto, Canada. · Department of Medical Imaging and Radiological Sciences, Chung Shan Medical University, Taichung, Taiwan. · Institute of Occupational Medicine and Industrial Hygiene, National Taiwan University College of Public Health, Taipei, Taiwan. · Department of Neurology, Kaoshiung Medical University Hospital, Kaoshiung, Taiwan. · Department of Environmental and Occupational Medicine, National Taiwan University Hospital, Taipei, Taiwan. · Pubmed 28257449
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Ontario, Canada; Department of Psychiatry, Samsung Seoul Hospital, Sungkyunkwan University, School of Medicine, Seoul, South Korea. · Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University, School of Medicine, Seoul, South Korea. · Departments of Preventive Medicine, School of Medicine, Kyung Hee University, Seoul, South Korea. · Cancer Registration and Statistic Branch, National Cancer Control Institute, National Cancer Center, Goyang, South Korea. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Ontario, Canada; Interdisciplinary Laboratory of Clinical Neurosciences (LINC), Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), Brazil. · Department of Medicine, Schulich School of Medicine and Dentistry, University of Western London, Ontario, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Institute of Medical Science, University of Tornoto, Toronto, Ontario, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Ontario, Canada; Institute of Medical Science, University of Tornoto, Toronto, Ontario, Canada; Department of Pharmacology, University of Toronto, Ontario, Canada. Electronic address: · Total Healthcare Center, Kangbuk Samsung Hospital, Sungkyunkwan University, School of Medicine, Seoul, South Korea; Departments of Preventive Medicine, School of Medicine, Kyung Hee University, Seoul, South Korea. Electronic address: · Pubmed 27810270
2016
  • 1Mood Disorders Psychopharmacology Unit,University Health Network,Toronto,Ontario,Canada. · Pubmed 28044944
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada. · Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada. · Pubmed 27935809
  • From the *Mood Disorders Psychopharmacology Unit, University Health Network; †Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada; ‡Psychiatric Center Copenhagen, Department O, Copenhagen, Denmark; and Departments of §Psychiatry and ∥Pharmacology, University of Toronto, Toronto, Ontario, Canada. · Pubmed 26658082
  • School of Medicine, Chang Gung University, Taoyuan, Taiwan; Department of Psychiatry, Chang Gung Memorial Hospital, Chiayi, Taiwan. · Department of Medical Imaging and Radiological Sciences, Chung Shan Medical University, Taichung, Taiwan; Department of Medical Imaging, Chung Shan Medical University Hospital, Taichung, Taiwan. · School of Medicine, Chang Gung University, Taoyuan, Taiwan; Department of Psychiatry, Chang Gung Memorial Hospital, Taoyuan, Taiwan. · Department of Medical Imaging and Radiological Sciences, Chung Shan Medical University, Taichung, Taiwan. · Department of Psychiatry, Chung Shan Medical University, Taichung, Taiwan. · Department of Neurosurgery, Chang Gung Memorial Hospital, Taoyuan, Taiwan. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada. · Department of Medical Imaging and Radiological Sciences, Chung Shan Medical University, Taichung, Taiwan; Department of Medical Imaging, Chung Shan Medical University Hospital, Taichung, Taiwan. Electronic address: · Pubmed 27423425
  • 1Department of Psychiatry,University of Toronto,Toronto,Ontario,Canada. · 3Mood Disorders Psychopharmacology Unit,University Health Network,Toronto,Ontario,Canada. · 5Department of Psychiatry,Psychiatric Center,Copenhagen,Denmark. · 6Cleveland Clinic,Cleveland,Ohio,USA. · 7Turn2Health Solutions,Willoughby,Ohio,USA. · 8Translational Psychiatry Research Group and Department of Clinical Medicine, Faculty of Medicine,Federal University of Ceara,Fortaleza,Brazil. · 9Department of Neuropsychiatry,University of South Carolina School of Medicine,Columbia,South Carolina,USA. · Pubmed 26714651
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Cleveland Clinic, Cleveland, OH, USA. · Turn2Health Solutions, Willoughby, OH, USA. · Translational Psychiatry Research Group and Department of Clinical Medicine, Faculty of Medicine, Federal University of Ceara, Fortaleza, Brazil. · Department of Neuropsychiatry, University of South Carolina School of Medicine, USA. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 26508286
2015
  • 1Department of Psychiatry,University of Toronto,Toronto,Ontario,Canada. · 3Mood Disorders Psychopharmacology Unit,University Health Network,Toronto,Ontario,Canada. · Pubmed 26683526
2017
  • From the *Mood Disorder Psychopharmacology Unit, University Health Network; †Brain and Cognition Discovery Foundation, ‡Department of Psychiatry, §Department of Pharmacology, and ∥Institute of Medical Science, University of Toronto, Toronto, ON, Canada; ¶Department of Psychiatry, University of Saskatchewan, Saskatoon, SK, Canada; #Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada; and **Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, SC. · Pubmed 28590365
2016
  • aDepartment of PsychiatrybDepartment of Pharmacology, University of TorontocMood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada. · Pubmed 26575300
University of Toronto
2019
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Institute of Medical Science, University of Toronto, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, Brazil. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Institute of Medical Science, University of Toronto, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Department of Pharmacology, University of Toronto, Toronto, Canada. Electronic address: · Pubmed 30795495
2018
  • From the Mood Disorders Psychopharmacology Unit, University Health Network, Canada · Institute of Medical Science (Drs. McIntyre and Rosenblat, Ms. Lee, and Mr. Pan), Department of Psychiatry (Drs. McIntyre, Rosenblat, and Mansur), and Department of Pharmacology (Dr. McIntyre), University of Toronto · Paik Institute for Clinical Research, Inje University (Republic of Korea) (Dr. J Lee) · Department of Psychiatry, Samsung Seoul Hospital, Sungkyunkwan University, School of Medicine (Republic of Korea) (Dr. J-G Lee) · Department of Psychiatry, College of Medicine, Imam University (Saudi Arabia) (Dr. Alageel). · Pubmed 30188336
  • Resident of Psychiatry, Clinician Scientist Stream, University of Toronto, Toronto, Ontario, Canada,. Electronic address: · Graduate Student, University of Toronto, Toronto, Ontario, Canada,. Electronic address: · Head, Mood Disorder Psychopharmacology Unit, University Health Network, Professor of Psychiatry and Pharmacology, University of Toronto, 399 Bathurst Street, MP 9-325, Toronto, Ontario M5T 2S8, Canada,. Electronic address: · Pubmed 30149336
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. Electronic address: · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, Federal University of São Paulo, São Paulo, SP, Brazil. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Brain and Cognition Discovery Foundation, Toronto, ON, Canada. · Pubmed 30031025
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Department of Psychiatry, Federal University of São Paulo, São Paulo 05403-903, Brazil. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON MT5 2S8, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON M5S 1A8, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON M5T 1R8, Canada. · Department of Pharmacology, University of Toronto, 399 Bathurst Street, Toronto, ON M5T 2S8, Canada. · Pubmed 29673146
  • Institute of Medical Science, University of Toronto, Toronto, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada. · Paik Institute for Clinical Research, Inje University, Busan, Republic of Korea; Department of Health Science and Technology, Graduate School, Inje University, Busan, Republic of Korea; Department of Psychiatry, School of Medicine, Haeundae Paik Hospital, Busan, Republic of Korea. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Ottawa, Ottawa, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, Universidade Federal de Sao Paulo, Sao Paulo, Brazil. · Department of Psychiatry, Ansan Hospital, College of Medicine, Korea University, Ansan, Republic of Korea. · Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. · Institute of Medical Science, University of Toronto, Toronto, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Department of Pharmacology, University of Toronto, Toronto, Canada. Electronic address: · Pubmed 29154157
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada; Research Group in Molecular and Behavioral Neuroscience of Bipolar Disorder, Department of Psychiatry, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil. · Faculty of Medicine, Queensland University, Brisbane, Queensland, Australia. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Brain and Cognition Discovery Foundation, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada. Electronic address: · Pubmed 28992527
  • Institute of Medical Science, University of Toronto, Toronto, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada. · Department of Mechanical and Industrial Engineering, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Department of Psychiatry, Federal University of Sao Paulo, Sao Paulo, Brazil. · Laboratory of Emotion and Cognition, Department of Affective Disorders, Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China; Department of Neuropsychology, University of Hong Kong, Hong Kong, China. · School of Medicine, Chang Gung University, Taoyuan, Taiwan; Department of Psychiatry, Chang Gung Memorial Hospital, Chiayi, Taiwan. · Department of Psychological Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. · Institute of Medical Science, University of Toronto, Toronto, Canada; Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada; Brain and Cognition Discovery Foundation, Toronto, Canada; Department of Psychiatry, University of Toronto, Toronto, Canada; Department of Pharmacology, University of Toronto, Toronto, Canada. Electronic address: · Pubmed 30153635
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, Samsung Seoul Hospital, Sungkyunkwan University, School of Medicine, Seoul, Republic of Korea. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Paik Institute for Clinical Research, Inje University, Busan, Republic of Korea. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, College of Medicine, Imam University, Riyadh, Saudi Arabia. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; American University of Integrative Sciences School of Medicine, Sint Maarten, The Netherlands. · Alzheimer Center, VU Medical Center, Amsterdam, The Netherlands; Metis Cognition Ltd., Warminster, UK. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 29886204
  • Dent Neurologic Institute, Amherst, NY, USA. · University at Buffalo School of Pharmacy and Pharmaceutical Sciences, Buffalo, NY, USA. · Mood Disorders Psychopharmacology Unit, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada. · Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada. · Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. · Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada. · Pubmed 29427512
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada. · Smofsky Strategic Planning, Oakville, Ontario, Canada. · AstraZeneca Canada, Mississauga, Ontario, Canada. · Lewis-Daly & Associates, Toronto, Ontario, Canada. · The Health Team, Toronto, Ontario, Canada. · Department of Health Research Methods, Evidence, and Impact; Center for Health Economics and Policy Analysis (CHEPA), McMaster University, Hamilton, Ontario, Canada; Research Institute at St Joes, St Joseph Healthcare Hamilton, Hamilton, Ontario, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Ontario, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada; Department of Pharmacology, University of Toronto, Toronto, Ontario, Canada. Electronic address: · Pubmed 28958785
2017
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · The Centre for Addiction and Mental Health (CAMH), Toronto, ON, Canada. · Department of Pharmacology, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Brain and Cognition Discovery Foundation, Toronto, ON, Canada. · Pubmed 28933261
  • Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON, Canada; American University of Integrative Sciences School of Medicine, Sint Maarten, The Netherlands. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON, Canada. · Department of Psychological Medicine, National University of Singapore, Singapore. · Mood Disorders Psychopharmacology Unit (MDPU), University Health Network, University of Toronto, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 28501518
  • Resident of Psychiatry, Clinician Scientist Stream, University of Toronto, Ontario, Canada. · Undergraduate Research Student, University of Toronto, Ontario, Canada. · 399 Bathurst St, MP 9-325, Toronto, Ontario M5T 2S8, Canada. · Department of Psychiatry and Pharmacology, Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Ontario, Canada. · Pubmed 28068459
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Janssen Research & Development, LLC, Raritan, USA. · Department of Psychiatry, St. Michael's Hospital, Toronto, ON, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Department of Psychiatry, University of Toronto, Toronto, ON, Canada. · Department of Pharmacology, University of Toronto, Toronto, ON, Canada. · Pubmed 27913990
  • Department of Psychiatry and Pharmacology, University of Toronto, Mood Disorders Psychopharmacology Unit, University Health Network, Brain and Cognition Discovery Foundation, 399 Bathurst St, Toronto, ON, Canada M5T 2S8. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, Canada. · Brain and Cognition Discovery Foundation (BCDF), Toronto, Canada. · Department of Psychiatry, University of Toronto, Toronto, Canada. · Department of Pharmacology, University of Toronto, Toronto, Canada. · Institute of Medical Science, University of Toronto, Toronto, Canada. · Department of Psychology, Queen's University, Kingston, Canada. · Centre for Addiction and Mental Health, Toronto, Canada. · Faculty of Medicine, University of Queensland, Brisbane, Australia. · Stoneylane Clinic Drogheda, Co Louth, Ireland. · Department of Psychiatry, University of Adelaide, Adelaide, Australia. · Department of Family Medicine, Boston University, Boston, Massachusetts, USA. · Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, Institut du Cerveau et de la Moelle, ICM, Social and Affective Neuroscience (SAN) Team, Paris, France. · Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, Texas, USA. · University Department of Psychiatry, Warneford Hospital, Oxford, United Kingdom. · Private practice, London, United Kingdom. · Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada. · Institute of Clinical Psychology and Psychotherapy and Centre of Clinical Epidemiology and Longitudinal Studies (CELOS), Technische Universität Dresden, Dresden, Germany. · Alzheimer Center, VU Medical Center, Amsterdam, the Netherlands. · Metis Cognition Ltd, Warminster, United Kingdom. · IoPPN, King's College, London, United Kingdom. · Pubmed 28858441
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, Samsung Seoul Hospital, Sungkyunkwan University, School of Medicine, Seoul, Republic of Korea. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Paik Institute for Clinical Research, Inje University, Busan, Republic of Korea. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, College of Medicine, Imam University, Riyadh, Saudi Arabia. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; American University of Integrative Sciences School of Medicine, Sint Maarten, The Netherlands. · Alzheimer Center, VU Medical Center, Amsterdam, The Netherlands; Metis Cognition Ltd., Warminster, UK. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada; Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Department of Pharmacology, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 28850348
  • Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Department of Psychiatry, Samsung Seoul Hospital, Sungkyunkwan University, School of medicine, Seoul, Republic of Korea. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Paik Institute for Clinical Research, Inje University, Busan, Republic of Korea. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; American University of Integrative Sciences, School of Medicine, Sint Maarten. · Associate Professor, Center for Depression Research and Clinical Care, Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA. · Associate Head for Research, Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada; Director, Mood Disorders Centre, Djavad Mowafaghian Centre for Brain Health, Vancouver, BC, Canada; Executive Chair, Canadian Network for Mood and Anxiety Treatments (CANMAT), Vancouver, BC, Canada. · Professor and Chair, Head of Discipline of Psychiatry, University of Adelaide, Adelaide, Australia. · Associate Professor, Alzheimer Center, VU Medical Center, Amsterdam, The Netherlands; Principal Consultant, Metis Cognition Ltd., Warminster, UK. · Mood Disorders Psychopharmacology Unit, University Health Network, Toronto, ON, Canada; Institute of Medical Science, University of Toronto, Toronto, ON, Canada; Professor, Department of Psychiatry, University of Toronto, Toronto, ON, Canada; Professor, Department of Pharmacology, University of Toronto, Toronto, ON, Canada. Electronic address: · Pubmed 28667888
  • Department of Psychiatry, Chang Gung Medical Foundation, Chiayi Chang Gung Memorial Hospital, Chiayi, Taiwan. · Department of Psychiatry, School of Medicine, Chang Gung University, Taoyuan, Taiwan. · Tsaotun Psychiatric Center, Ministry of Health and Welfare, Nan-Tou County, Taiwan. · PhD Student of Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan. · Department of Psychiatry, Cathay General Hospital, Taipei, Taiwan. · College of Medicine, Fu Jen Catholic University, Taipei, Taiwan. · Mood Disorders Psychopharmacology Unit, University Health Network, University of Toronto, Toronto, Canada. · Departments of Psychiatry and Pharmacology, University of Toronto, Toronto, Canada. · Department of Medical Imaging and Radiological Sciences, Chung Shan Medical University, Taichung, Taiwan. · Institute of Occupational Medicine and Industrial Hygiene, National Taiwan University College of Public Health, Taipei, Taiwan. · Department of Neurology, Kaoshiung Medical University Hospital, Kaoshiung, Taiwan. · Department of Environmental and Occupational Medicine, National Taiwan University Hospital, Taipei, Taiwan. · Pubmed 28257449
2016
  • From the *Mood Disorders Psychopharmacology Unit, University Health Network; †Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada; ‡Psychiatric Center Copenhagen, Department O, Copenhagen, Denmark; and Departments of §Psychiatry and ∥Pharmacology, University of Toronto, Toronto, Ontario, Canada. · Pubmed 26658082
2017
  • From the *Mood Disorder Psychopharmacology Unit, University Health Network; †Brain and Cognition Discovery Foundation, ‡Department of Psychiatry, §Department of Pharmacology, and ∥Institute of Medical Science, University of Toronto, Toronto, ON, Canada; ¶Department of Psychiatry, University of Saskatchewan, Saskatoon, SK, Canada; #Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada; and **Department of Neuropsychiatry and Behavioral Science, University of South Carolina School of Medicine, Columbia, SC. · Pubmed 28590365
Sungkyunkwan University
2018
  • From the Mood Disorders Psychopharmacology Unit, University Health Network, Canada · Institute of Medical Science (Drs. McIntyre and Rosenblat, Ms. Lee, and Mr. Pan), Department of Psychiatry (Drs. McIntyre, Rosenblat, and Mansur), and Department of Pharmacology (Dr. McIntyre), University of Toronto · Paik Institute for Clinical Research, Inje University (Republic of Korea) (Dr. J Lee) · Department of Psychiatry, Samsung Seoul Hospital, Sungkyunkwan University, School of Medicine (Republic of Korea) (Dr. J-G Lee) · Department of Psychiatry, College of Medicine, Imam University (Saudi Arabia) (Dr. Alageel). · Pubmed 30188336
Miscellaneous cities in Korea
2018
  • From the Mood Disorders Psychopharmacology Unit, University Health Network, Canada · Institute of Medical Science (Drs. McIntyre and Rosenblat, Ms. Lee, and Mr. Pan), Department of Psychiatry (Drs. McIntyre, Rosenblat, and Mansur), and Department of Pharmacology (Dr. McIntyre), University of Toronto · Paik Institute for Clinical Research, Inje University (Republic of Korea) (Dr. J Lee) · Department of Psychiatry, Samsung Seoul Hospital, Sungkyunkwan University, School of Medicine (Republic of Korea) (Dr. J-G Lee) · Department of Psychiatry, College of Medicine, Imam University (Saudi Arabia) (Dr. Alageel). · Pubmed 30188336
3 Other Locations Show
Yearly article counts 11014710000000
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.